Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis

Dipankar Bhattacharya(Ashoka University), Scott L. Friedman(Icahn School of Medicine at Mount Sinai)
Scientific Reports
October 21, 2021
Cited by 18


Related Papers